Loading...
Thumbnail Image
Item

Naltrexone: The Treatment for Alcohol Use Disorder that is Hiding in Plain Sight

Advisor
Date
2025-07-25
Embargo until
Language
Book title
Journal
Publisher
Chestnut Health Systems, Lighthouse Institute
Peer Reviewed
Type
Article
Research Area
Jurisdiction
Other Titles
See at
Abstract

According to the CDC, every year, about 178,000 Americans die from alcohol-related causes, and that number has nearly doubled since the COVID-19 lockdowns.[1] Alcohol use is also tied to over 200 major health problems, yet it often goes ignored in doctors’ offices.[2] That’s troubling enough, but here’s something even more surprising: a medication that could help millions of patients is barely being used. As of 2025, the use of medications to treat alcohol use disorder (AUD) is a well-established part of evidence-based treatment, though still underutilized in many, if not most, settings (National Institute on Alcohol Abuse and Alcoholism). While the world buzzes about trendy new weight- loss drugs like Ozempic, a decades-old proven medication called naltrexone could be making just as big a difference in substance use treatment, if only more people knew and understood what it can do.

Data Availibility
Data / Code Location
Table of Contents
Description
Article published in Chestnut Health Systems' newsletter, The Catalyst.
Series/Report No.
Sponsors
Rights/Terms
Citation
Identifier to cite or link to this item
Scopus Identifier
Embedded videos